Concept Medical at NYEVS 2026 | New York Endovascular Summit
NYEVS 2026 · New York Endovascular Summit

Concept Medical at NYEVS 2026

Advancing Vascular Intervention With Sirolimus Drug Delivery

24–26 September 2026
New York Marriott Marquis · 1535 Broadway, New York, NY 10036

About the Summit

What Is the New York Endovascular Summit 2026?

The 2026 New York Endovascular Summit (NYEVS) is a three-day multidisciplinary conference focused on the diagnosis and treatment of peripheral vascular disease, with tracks covering non-aortic PAD, aortic disease and podiatry.

The programme combines didactic sessions with live cases transmitted from leading centres worldwide, bringing together vascular surgeons, interventional cardiologists, vascular medicine specialists, podiatrists, nurses and cath-lab technologists. Its objective is an interdisciplinary forum showcasing the most effective approaches to managing peripheral artery disease.

  • PAD Symposium
  • Aortic
  • Podiatry
  • PE & Venous
  • Fellows Course
  • Aortic Bootcamp

Visit the official NYEVS website →

3
DaysThursday 24 – Saturday 26 September 2026
NYC
New York Marriott Marquis1535 Broadway, New York, NY 10036
4
Clinical TracksNon-aortic PAD, aortic, podiatry, PE & venous — plus two fellows courses

Concept Medical at NYEVS 2026

Where to Find Us in New York

Three scientific presentations on MagicTouch PTA across Friday and Saturday, and our team on the exhibition floor throughout the summit.

Presentations

3

MagicTouch PTA sessions — SIRPAD, SIRONA 2 and the HOPE Registry.

Booth

Number TBD

Exhibition hall, New York Marriott Marquis. Booth number will be confirmed here.

Faculty

3

Sabine Steiner, Andrej Schmidt and Edward Choke present the latest data.

Meetings

1:1

Book time with our clinical and commercial team during the summit.

Schedule a meeting →

Featured Technology

Sirolimus Drug-Coated Balloon for Peripheral Intervention

MagicTouch PTA sirolimus drug-coated balloon

MagicTouch PTASirolimus drug-coated balloon

MagicTouch PTA is Concept Medical's sirolimus drug-coated balloon for peripheral artery disease. At NYEVS 2026 it is the subject of three scientific presentations spanning a randomised controlled trial, a clinical trial update and a real-world registry.

  • Fri · 2:45 PMSIRPAD Trial: Key Takeaways and Clinical Implication
  • Fri · 3:45 PMSIRONA 2 RCT: Update on 2-Year Results
  • Sat · 2:10 PMUpdate of HOPE Registry
Learn More

Clinical & Scientific Evidence

The Evidence Presented at NYEVS 2026

Three datasets on MagicTouch PTA, presented by the investigators themselves.

Clinical trial

SIRPAD Trial

Key takeaways and clinical implication, presented by Sabine Steiner.

Friday 25 September · 2:45 PM · See schedule
Randomised controlled trial

SIRONA 2 RCT

Update on two-year results, presented by Andrej Schmidt.

Friday 25 September · 3:45 PM · See schedule
Registry

HOPE Registry

Registry update, presented by Edward Choke.

Saturday 26 September · 2:10 PM · See schedule

Schedule

Concept Medical Sessions at NYEVS 2026

All times local (EDT). Room details will be published when confirmed by the summit.

Friday, 25 September 2026

SIRPAD Trial: Key Takeaways and Clinical Implication
Sabine Steiner
MagicTouch PTANew York Marriott Marquis
SIRONA 2 RCT: Update on 2-Year Results
Andrej Schmidt
MagicTouch PTANew York Marriott Marquis

Saturday, 26 September 2026

Update of HOPE Registry
Edward Choke
MagicTouch PTANew York Marriott Marquis

Meet the Experts

Presenting Faculty

Sabine Steiner

Sabine Steiner

SIRPAD Trial: Key Takeaways and Clinical ImplicationFriday 25 September · 2:45 PM
Andrej Schmidt

Andrej Schmidt

SIRONA 2 RCT: Update on 2-Year ResultsFriday 25 September · 3:45 PM
Edward Choke

Edward Choke

Update of HOPE RegistrySaturday 26 September · 2:10 PM

NYEVS 2026 · 24–26 September · New York

Let's Connect at NYEVS 2026

Meet the Concept Medical team and discover our latest innovations in vascular intervention.

Conference information sourced from nyevs.org. Product information is intended for healthcare professionals. Please refer to the Instructions for Use for indications, contraindications and warnings.